A drug combination – of lapatinib and trastuzumab (Herceptin) – before surgery shrinks and may even destroy tumours in women with HER2 positive disease within 11 days, according to new research.
Drug combination shrinks HER2-positive breast cancers within 11 days. The Institute of Cancer Research. http://www.icr.ac.uk/news-archive/drug-combination-shrinks-her2-positive-breast-cancers-within-11-days?utm_content=bufferca684&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer
No comments:
Post a Comment
Please let me know what you think or what you want to know more about!